Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · CIOC 2027

Gut microbiota implications in Cancer at CIOC 2027

Part of the CIOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Gut microbiota implications in Cancer Session

Cancer is a complex disease that is the world's second biggest cause of mortality. Numerous studies in recent years have underlined the dual significance of the gut microbiota in sustaining the health of the host. The term "gut microbiota" refers to the diverse population of commensal microorganisms, mainly bacteria but also fungi, archaea, and viruses that populate the intestinal tract, particularly the large intestine, and it can be thought of as one factor to which we are constantly exposed, at high doses, throughout our lives. The gastro-intestinal resident bacteria and the human body interact at a sophisticated level in the gut. Gut bacteria can produce a variety of metabolites and bioproducts that help to maintain homeostasis in both the host and the gut.

  • Gut Microbiota and Host’s Tumorigenesis
  • Microbial biomarkers
  • Gut Microbiota and the Inflammasomes
  • Faecal Microbiota Transplantation (FMT)
  • Probiotics in Cancer
  • Bacteria Based Therapies

Topics Covered in Gut microbiota implications in Cancer

Topic 01

Dysbiosis & Carcinogenesis

Topic 02

Microbial Metabolites

Topic 03

Immunotherapy Response

Topic 04

Colorectal Cancer Risk

Topic 05

Fecal Microbiota Transplant

Topic 06

Probiotics & Diet

Related Scientific Sessions at CIOC 2027

Why Attend the Gut microbiota implications in Cancer Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Gut microbiota implications in Cancer work, reviewed by the scientific committee.

Network Globally

Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Gut microbiota implications in Cancer research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join CIOC 2027 for the Gut microbiota implications in Cancer track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Gut microbiota implications in Cancer Conference 2027 — FAQs

What is the Gut microbiota implications in Cancer track at CIOC 2027?

The Gut microbiota implications in Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gut microbiota implications in Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Gut microbiota implications in Cancer sessions?

Cancer researchers and clinicians, educators and students with an interest in Gut microbiota implications in Cancer are all welcome — whether presenting or attending.

Can I present my research in the Gut microbiota implications in Cancer track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Gut microbiota implications in Cancer sessions?

Yes. CIOC 2027 is a hybrid conference — attend the Gut microbiota implications in Cancer track in person in Singapore or join live online, with on-demand access afterward.

Join the CIOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us